Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Uncategorized

March 21, 2017 – Earlier this month, Republican leaders in the House of Representatives introduced the American Health Care Act (AHCA) to replace the Affordable Health Care Act (ACA) passed in March 2010. The ACA, also known as Obamacare, has several key components that protects access to health care for people with pre-existing conditions and/or chronic […]

Read More


Each year, thousands of doctors, scientists, students, industry and patient advocacy groups like National Eczema Association, gather to hear the latest research and standards of medical care in dermatology at the American Academy of Dermatology (AAD) Annual Meeting. Atopic dermatitis is a hot field of study. Here’s some highlights from this year’s AAD meeting. Biologic […]

Read More


Pain and poor sleep – two symptoms common to people with atopic dermatitis. When these symptoms spin out of control, every part of one’s life is impacted. To find out more about why and how pain and sleep problems affect people with atopic dermatitis, the National Eczema Association funded three studies in these areas as […]

Read More


January 9. 2017 — Last week, a panel of experts sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) released new guidelines for reducing the risk of peanut allergies in children. This panel, which included National Eczema Association, recommended giving children 6 months and younger peanut-containing foods under the direction of a pediatrician or […]

Read More


By Christopher Logas and Peter A. Lio, MD We share a lot with our beloved canines: our home, our bed and sometimes, even our dinner. But did you know that humans share something else with dogs? A diagnosis of atopic dermatitis (AD). Dogs with canine atopic dermatitis (CAD) have many of the same symptoms as […]

Read More


What is atopic dermatitis (AD)? AD is a severe form of eczema, which is an umbrella term used to describe a group of conditions that result in itchy, red, and irritated skin. It is a chronic, inflammatory disease that results in red, itchy patches on the skin that can crack and weep. AD falls into […]

Read More


December 20, 2016 — On December 14, the U.S. Food and Drug Administration approved Eucrisa (crisaborole), a topical treatment for children and adults with mild to moderate atopic dermatitis (AD). This marks the first new FDA-approved medication for atopic dermatitis in more than 10 years. “It’s a big deal because for at least 15 years, […]

Read More


December 20, 2016 — This year has been a busy one for eczema research. Currently, there are more than 40 therapies in development for eczema that have the potential to help symptoms such as itch and redness, improve the skin barrier and calm the immune system. Scientists are also looking at how eczema affects the […]

Read More


December 14, 2016 — People with atopic dermatitis have a new treatment option. Today, the U.S. Food and Drug Administration approved Eucrisa (crisaborole), a topical treatment for children and adults with mild to moderate atopic dermatitis (AD). Eucrisa works differently than other topical treatments on the market. It is not a steroid or a topical […]

Read More


December 6, 2016 – NEA’s Chicago Support Group recently hosted a meeting, which included guest speakers Peter A. Lio, MD, NEA Scientific Advisory Committee member and Dr. Richard Aron. Dr. Aron is a South African dermatologist, specializing in Atopic Eczema, and he has created “The Aron Regime.” Following the Chicago event, Dr. Lio shared his […]

Read More